(Q30446891)

English

Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

based on heuristic

inferred from title

object named as

Kevin T Hogan

2

0 references

author name string

Sara J Adair

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

publication date

13 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

589-601

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0582-6

21 January 2018

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0582-6

21 January 2018

Sequence and expression pattern of the human MAGE2 gene

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0582-6

21 January 2018

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0582-6

21 January 2018

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0582-6

21 January 2018

Absence of HeLa cell contamination in 169 cell lines derived from human tumors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/58.2.209

Identifiers

10.1007/S00262-008-0582-6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30446891&oldid=2194862922"